cbdMD (YCBD) Long-Term Investments (2017 - 2026)
cbdMD (YCBD) posted Long-Term Investments of $700000.0 for Q4 2025, little changed sequentially from $700000.0 in Q3 2025, and little changed YoY from $700000.0 in Q4 2024.
cbdMD (YCBD) Long-Term Investments (2017 - 2026) Analysis & Trends
cbdMD has reported Long-Term Investments for 9 years, with the latest figure at $700000.0 in Q4 2025.
- Quarterly Long-Term Investments changed 0.0% year-over-year to $700000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $700000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $700000.0, changed 0.0% from the prior year.
- Long-Term Investments steadied at $700000.0 in Q4 2025 per YCBD's latest filing, from $700000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.4 million in Q2 2022 and troughed at $700000.0 in Q3 2023.
- A 5-year average of $947368.4 and a median of $700000.0 in 2023 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2021 and 2023: Long-Term Investments soared 300.0% in 2021, then plunged 50.0% in 2023.
- Over 5 years, Long-Term Investments stood at $1.0 million in 2021, then jumped by 40.0% to $1.4 million in 2022, then slumped by 50.0% to $700000.0 in 2023, then changed by 0.0% to $700000.0 in 2024, then changed by 0.0% to $700000.0 in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $700000.0, $700000.0, and $700000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |